WallStreetZenWallStreetZen

NASDAQ: LUMO
Lumos Pharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LUMO past revenue growth

How has LUMO's revenue growth performed historically?
Company
34.67%
Industry
154.55%
Market
17.87%
LUMO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LUMO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LUMO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LUMO earnings and revenue history

Current Revenue
$2.1M
Current Earnings
-$34.0M
Current Profit Margin
-1,659.4%

LUMO Return on Equity

Current Company
-85.6%
Current Industry
-63.5%
Current Market
188%
LUMO's Return on Equity (-85.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LUMO announces earnings.

LUMO Return on Assets

Current Company
-65.3%
Current Industry
2.9%
LUMO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LUMO Return on Capital Employed

Current Company
-101.35%
Current Industry
19.5%
LUMO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LUMO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LUMO$2.05M-$34.02M-$34.03M-30.31%N/A
BIVI$0.00-$39.04M-$43.27MN/AN/A
RNXT$0.00-$10.12M-$10.23MN/AN/A
APTO$0.00-$50.74M-$51.21MN/AN/A
AKTX$0.00-$10.00M-$10.01MN/AN/A
View Top Biotech Stocks

LUMO earnings dates

Next earnings date
May 1, 2024

Lumos Pharma Earnings & Revenue FAQ

What were LUMO's earnings last quarter?

On Invalid Date, Lumos Pharma (NASDAQ: LUMO) reported Q4 2023 earnings per share (EPS) of -$1.17, up 19.39% year over year. Total Lumos Pharma earnings for the quarter were -$9.46 million. In the same quarter last year, Lumos Pharma's earnings per share (EPS) was -$0.98.

If you're new to stock investing, here's how to buy Lumos Pharma stock.

What was LUMO's earnings growth in the past year?

As of Q2 2024, Lumos Pharma's earnings has grown year over year. Lumos Pharma's earnings in the past year totalled -$34.03 million.

What is LUMO's earnings date?

Lumos Pharma's earnings date is Invalid Date. Add LUMO to your watchlist to be reminded of LUMO's next earnings announcement.

What was LUMO's revenue last quarter?

On Invalid Date, Lumos Pharma (NASDAQ: LUMO) reported Q4 2023 revenue of $826.00 thousand up 61.33% year over year. In the same quarter last year, Lumos Pharma's revenue was $512.00 thousand.

What was LUMO's revenue growth in the past year?

As of Q2 2024, Lumos Pharma's revenue has grown 34.67% year over year. This is 119.89 percentage points lower than the US Biotechnology industry revenue growth rate of 154.55%. Lumos Pharma's revenue in the past year totalled $2.05 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.